Main Library

More than 80% of C-suite executives from healthcare and life sciences organizations see improved health equity as a top-10 goal for 2024, a recent report by Deloitte found.

The report offered a 2024 outlook for health equity across the two industries and relied on data from a survey conducted by the Deloitte Center for Health Solutions. The survey reached 53 health equity leaders and 121 healthcare and life sciences executives.

Deloitte defines health equity as the fair and just opportunity for all to achieve their full potential in every aspect of their health, regardless of who they are or where they are from.

The report found that nearly 50% of respondents expect to increase equity investments next year.

Realizing ROI from high-quality care requires intentional strategy and time, the report said. Short-term, these investments could lead to better recruitment, retention or operations. Long-term, health equity could positively impact every aspect of business.

Full Article